These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8077792)

  • 1. Need to expand microvascular investigation of patients with Raynaud's phenomenon of different etiology: clinical patterns of 106 consecutive patients.
    Arpaia G; Cimminiello C; Bellone M; Aloisio M; Rossi F; Bonfardeci G
    Int Angiol; 1994 Mar; 13(1):15-8. PubMed ID: 8077792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.
    Hirschl M; Hirschl K; Lenz M; Katzenschlager R; Hutter HP; Kundi M
    Arthritis Rheum; 2006 Jun; 54(6):1974-81. PubMed ID: 16732585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raynaud's phenomenon as an early sign of connective tissue diseases.
    Kallenberg CG
    Vasa Suppl; 1992; 34():25-8. PubMed ID: 1529414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of connective tissue disease in patients with Raynaud's phenomenon.
    Kallenberg CG
    Rheum Dis Clin North Am; 1990 Feb; 16(1):11-30. PubMed ID: 2406802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease.
    Houtman PM; Kallenberg CG; Fidler V; Wouda AA
    J Rheumatol; 1986 Jun; 13(3):556-63. PubMed ID: 3735277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of clinical signs and symptoms in patients with Raynaud's phenomenon. A cross-sectional study.
    Wollersheim H; Thien T
    Neth J Med; 1990 Dec; 37(5-6):171-82. PubMed ID: 2074908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications for nailbed capillaroscopy in Raynaud's phenomenon].
    Chamot AM; Monti M
    Schweiz Med Wochenschr; 1985 Dec; 115(51):1852-7. PubMed ID: 4089584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raynaud's phenomenon: clinical spectrum of 118 patients.
    De Angelis R; Del Medico P; Blasetti P; Cervini C
    Clin Rheumatol; 2003 Oct; 22(4-5):279-84. PubMed ID: 14576990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nailfold capillaroscopy in the evaluation of Raynaud's phenomenon and undifferentiated connective tissue disease].
    Cortes S; Clemente-Coelho P
    Acta Reumatol Port; 2008; 33(2):203-9. PubMed ID: 18604184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary function in patients presenting with Raynaud's phenomenon without an underlying connective tissue disease. A prospective, longitudinal study.
    Aalbers R; Groen H; Postma DS; Van der Mark TW; Wouda AA; Reig RP; Kallenberg CG
    J Rheumatol; 1989 Jan; 16(1):36-41. PubMed ID: 2785598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
    Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
    Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial prevalence and incidence of secondary Raynaud's phenomenon in patients with Raynaud's symptomatology.
    Hirschl M; Kundi M
    J Rheumatol; 1996 Feb; 23(2):302-9. PubMed ID: 8882036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of Raynaud's phenomenon].
    Guilmot JL; Diot E; Lasfargues G
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1755-60. PubMed ID: 1685081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Raynaud phenomenon in childhood: review and progress control in eight cases].
    González Pascual E; Esquinas Rychen G; Ruiz España A; Ros Viladoms JB; Juanola Roura X
    An Esp Pediatr; 1998 Jun; 48(6):603-7. PubMed ID: 9662844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Raynaud's phenomenon; diagnosis and treatment].
    Hofstee HM; Voskuyl AE; Serné EH; Smulders YM
    Ned Tijdschr Geneeskd; 2009; 153():B216. PubMed ID: 19785782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capillaroscopy.
    Cutolo M; Pizzorni C; Sulli A
    Best Pract Res Clin Rheumatol; 2005 Jun; 19(3):437-52. PubMed ID: 15939368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction.
    Dinerman H; Goldenberg DL; Felson DT
    J Rheumatol; 1986 Apr; 13(2):368-73. PubMed ID: 3487650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.